MCP-1 binding nucleic acids

US10273480B2 · kind B2 · utility

Assignee

• NOXXON Pharma AG · DE

Inventors

• Werner Purschke · Berlin, DE
• Florian Jarosch · Berlin, DE
• Dirk Eulberg · Berlin, DE
• Sven Klussmann · Berlin, DE
• Klaus Buchner · Schaffhausen, CH
• Christian Maasch · Berlin, DE

Key dates

• Filing date: Jun 6, 2017
• Grant date: Apr 30, 2019
• Expiry date: Jun 6, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/351
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention is related to a nucleic acid, preferably binding to MCP-1, selected from the group comprising type 1A nucleic acids, type 1B nucleic acids, type 2 nucleic acids, type 3 nucleic acids, type 4 nucleic acids and nucleic acids having a nucleic acid sequence according to any of SEQ.ID.No. 87 to 115.